General Information of Drug (ID: DMIMJNB)

Drug Name
MDR-101
Indication
Disease Entry ICD 11 Status REF
Kidney transplant rejection NE84 Phase 3 [1]
Drug Type
Cell therapy
Cross-matching ID
TTD ID
D8D1MI

References

1 ClinicalTrials.gov (NCT03363945) Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants. U.S. National Institutes of Health.